Bench Press: BioWorld Looks at Translational Medicine
Monday, July 29, 2013
Scientists from the Aaron Diamond AIDS Research Center have described bispecific antibodies that were able to neutralize more than 100 HIV strains at very low concentrations, suggesting that such antibodies might be useful for either treatment of HIV-infected individuals or pre-exposure prophylaxis.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.